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he granting of clinical staff privileges to physicians is a
rimary mechanism used by institutions to uphold the
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Health Care Organizations requires that the granting o
continuing medical staff privileges be based on assessment
of applicants against professional criteria specified in the
medical staff bylaws. Physicians themselves are thus charged
with identifying the criteria that constitute professiona
competence and with evaluating their peers accordingly. Ye
the process of evaluating physicians’ knowledge and com-
petence is often constrained by the evaluator’s own knowl-
edge and ability to elicit the appropriate information
problems compounded by the growing number of highly
specialized procedures for which privileges are requested.
The American College of Cardiology Foundation
American Heart Association/American College of Physi-
cians (ACCF/AHA/ACP) Task Force on Clinical Compe-
tence and Training was formed in 1998 to develop
recommendations for attaining and maintaining the cogni-
tive and technical skills necessary for the competent perfor-
mance of a specific cardiovascular service, procedure, o
technology. These documents are evidence based, and
where evidence is not available, expert opinion is utilized to
formulate recommendations. Indications and contraindica-
tions for specific services or procedures are not included in
the scope of these documents. Recommendations are in-
tended to assist those who must judge the competence o
cardiovascular health care providers entering practice for the
first time and/or those who are in practice and undergo
periodic review of their practice expertise. The assessment o
competence is complex and multidimensional; therefore
isolated recommendations contained herein may not neces-
sarily be sufficient or appropriate for judging overall com-
petence. The current document addresses competence in
electrophysiology, catheter ablation, and cardioversion and
is authored by representatives of the ACCF, the AHA, and
the Heart Rhythm Society (HRS).
The ACCF/AHA/ACP Task Force makes every effort to
avoid any actual or potential conflicts of interest that migh
arise as a result of an outside relationship or a persona
interest of a member of the ACCF/AHA/ACP Writing
Committee. Specifically, all members of the Writing Com-
mittee are asked to provide disclosure statements of all such
relationships that might be perceived as real or potentia
conflicts of interest relevant to the document topic. These
changes are reviewed by the Writing Committee and
updated as changes occur. The relationships with industry
information for authors and peer reviewers are published in
Appendix 1 and Appendix 2, respectively.
Mark A. Creager, MD, FACC, FAHA, Chai
ACCF/AHA/ACP Task Force on Clinical Competenc
and Training
INTRODUCTION
This statement is a revision and extension of the 2000
ACP/ACC/AHA document on clinical competence in
invasive cardiac electrophysiologic studies (EPS) (1), 1994
ACP/ACC/AHA competency document, and the 1993report on elective direct current cardioversion (DCCV) (2)
This statement is designed to assist in the assessment o
physicians’ competence on a procedure-specific basis. The
minimum education, training, experience, and cognitive and
technical skills necessary for the competent performance o
invasive cardiac EPS, catheter ablation, and cardioversion
are specified. It is important to note that these are the
minimum training and experience requirements for the
assessment of competence in these disciplines (or proce-
dures) in the broadest sense. Whenever possible, the spec-
ifications are based on published data that link these factor
with competence or, in the absence of such data, on the
consensus of expert opinion. The specifications are applica-
ble to any practice setting and can accommodate a numbe
of ways in which physicians can substantiate competence in
the performance of specific procedures (3). Expertise in the
performance of these procedures in patients with infre-
quently encountered diagnoses or of less commonly per-
formed variations of standard procedures may require addi-
tional experience or training. It is therefore expected tha
even highly competent practitioners will occasionally benefi
from consultation with colleagues who have even more
highly specialized interests, experience, or skills. This doc-
ument in large part does not deal with pacing and defibril-
lator therapies. Competencies regarding these devices are
covered in the HRS competency statement (4).
In addition to members of ACC and AHA, the Writing
Committee included a representative from the HRS. Rep-
resentation by an outside organization does not necessarily
imply endorsement. In addition to content peer reviewers
“official” reviewers were provided by ACC and AHA. Thi
document was approved for publication by the governing
bodies of ACC and AHA. In addition, HRS’s governing
board formally endorsed this document.
CLINICAL COMPETENCE IN INVASIVE EPS,
CATHETER ABLATION, AND CARDIOVERSION:
OVERVIEW OF THE PROCEDURE
Catheter techniques for the recording of the His bundle
potential in humans were first reported in 1969 by Scherlag
et al. (5). Initially, data from EPS were used to determine
the mechanisms of spontaneously occurring arrhythmias
including atrioventricular (AV) conduction abnormalities
premature complexes, and a variety of tachycardias (6,7)
Subsequently, techniques for programmed electrical stimu-
lation were developed, which permitted the reproducible
initiation of both supraventricular (7,8) and ventricula
(9–11) arrhythmias in the laboratory. Pacing protocols to
characterize sinus node function (12) and AV conduction
(13) were also introduced. Because sustained arrhythmia
are often episodic in nature or can terminate spontaneously
or require intervention before full clinical evaluation, inva-
sive EPS have become a standard means of reproducing an
arrhythmia in a controlled laboratory setting.In this report, the term “EPS” refers to a procedure that
involves the recording of intracardiac electrical signals and
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October 3, 2006:1503–17 ACC/AHA/ACP Clinical Competence Statementprogrammed electrical stimulation. The EPS either may be
performed for diagnostic purposes only or may be part of a
combined diagnostic and therapeutic (e.g., ablation) proce-
dure. Although a thorough description of EPS is beyond the
scope of this document, the procedure is briefly outlined
here.
An EPS requires the placement of electrode catheters fo
pacing and recording in multiple cardiac chambers. The
designs of the catheters and the sites appropriate for thei
placement are determined according to the nature of the
arrhythmia under investigation. Typically, each catheter wil
have multiple electrode poles for both recording and loca
stimulation. Many types of specially designed catheters have
been developed to facilitate recording and stimulation, and
new catheters are frequently introduced into clinical prac-
tice. The intracardiac signals are acquired, amplified, fil-
tered, displayed, stored, and analyzed, either in real time o
for subsequent offline review. A potentially important par
of an EPS is the use of intracardiac recordings to determine
activation sequences during arrhythmias. This process i
usually called “mapping.” Analysis of the responses of an
arrhythmia to various pacing techniques is also a componen
of the mapping process.
Electrophysiologic studies provide clinically valuable di-
agnostic information. In patients with bradyarrhythmias
EPS are occasionally necessary to clarify electrocardio-
graphic phenomena or to explain symptoms that are possi-
bly due to a transient, clinical bradyarrhythmia. Electro-
physiologic studies are useful to determine the mechanism
and physiological characteristics and drug responses o
supraventricular tachycardias and to determine whethe
arrhythmias are suitable for drug, device, or ablation ther-
apy, as described later in this document. In patients with
ventricular tachycardia, EPS are useful to confirm the mecha-
nism of the arrhythmia, to assess the effects of pharmacologic
therapy, and to select patients for nonpharmacologic treat-
ment. Acute or follow-up testing for antiarrhythmic device
efficacy falls under the definition of “EPS.” These studie
can often be performed noninvasively through the device
but the placement of temporary catheters may be necessary
Electrophysiologic studies have also been used to asses
the future risk of serious antiarrhythmic events and to
provide data on which prophylactic therapy may be based
Table 1. Invasive Electrophysiologic Studies (EPS): Recommend
Source Training, yrs EPS, n
ACP/ACC/AHA 1994* 1 100
Canadian Cardiovascular Society (19)
Level 2 1–2 100
Level 3* 1–2 NS
British Cardiac Society (20)* 1 70
COCATS (21)* 1 100
ACGME (22)* 1 150
ABIM (23)* 1 159
Present document* 1 100*Recommendations for last year of training. †Not including 30–50 if training in atrial fib
n  number performed or implanted; NS  not specified.(14). In patients with undocumented symptoms that sugges
an arrhythmia that was not previously documented (e.g.
syncope or palpitations), EPS are frequently used to asses
the patient’s predisposition for spontaneously occurring
arrhythmias (15).
Physicians involved in the performance of invasive EPS
should be cognizant of the indications, contraindications
and potential complications of the procedure in a given
patient (15,16). Absolute contraindications to EPS are few
but include unstable angina, bacteremia or septicemia, acute
decompensated congestive heart failure not caused by the
arrhythmia, major bleeding diathesis, and acute lower ex-
tremity venous thrombosis, if femoral vein cannulation i
desired. The appropriate use of invasive EPS, therefore
requires a careful nonprocedural assessment to ensure tha
the patient is stable and able to tolerate the procedure. In the
vast majority of situations, an EPS is performed on an elective
basis. However, an EPS is justifiable in such situations if an
arrhythmia is the main or major cause of the emergency, a
occurs in patients with incessant ventricular or supraventric-
ular tachycardia. General indications for invasive EPS were
described by the ACC/AHA Task Force on Practice
Guidelines, in conjunction with the HRS (17).
JUSTIFICATION FOR RECOMMENDATIONS
The recommendations for minimum education, training
experience, and skills necessary to perform EPS are based on
a review of statements by the ACP, the ACC, and the AHA
(1,18); the Canadian Cardiovascular Society (19); and the
British Cardiac Society and Royal College of Physician
(20); a report from a Core Cardiology Training Symposium
(COCATS) (21); and policies of the Accreditation Council o
Graduate Medical Education (ACGME) (22) and the Amer-
ican Board of Internal Medicine (ABIM) (23) (Table 1). The
American groups (Table 1) recommend training after the
completion of 3 years of a general cardiology fellowship
The British statement discusses specialized training in the
last year (year 6) of a cardiology fellowship. The Canadian
Cardiovascular Society describes 2 levels of specialized
training: Level 2 may be achieved during 3 years of a genera
cardiology fellowship program, whereas Level 3 require
additional years of training. In preparation of this docu-
for Training to Achieve Competence
EPS in Patients With
Supraventricular Tachycardia, n
Catheter
Ablation, n
Antiarrhythmic
Devices, n
NS NS NS
NS NS NS
NS NS NS
NS 50 NS
50 50 50
NS 75 25
NS 75 25
50 50–75† NSationrillation ablation is pursued.
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ACC/AHA/ACP Clinical Competence Statement October 3, 2006:1503–17ment, 63 program directors were surveyed regarding train-
ing and competency issues; 33 directors (52.4%) responded
Where results pertaining to this document are available
they will be indicated as Clinical Cardiac Electrophysiology
(CCEP) Training Program Directors’ Survey results.
The technical and cognitive skills required for CCEP are
listed in Tables 2 and 3. Expertise in invasive EPS require
the ability to safely and efficiently perform the catheteriza-
tion procedures for intracardiac recording and stimulation
The operator must possess a thorough understanding of the
basic electrophysiologic mechanisms and clinical manifesta-
tions of arrhythmias; the applications and limitations of the
available recording and stimulation technologies; the phar-
macologic effects of medications used during the studies
and the risks, benefits, and applications of nonpharmaco-
logic therapy. Because knowledge in all of these areas ha
increased, the interpretation and application of data ac-
quired in the electrophysiologic laboratory have become
increasingly complex. The accurate interpretation of data i
critical for optimal prescription of both pharmacologic and
nonpharmacologic therapies.
MINIMUM TRAINING NECESSARY FOR COMPETENCE
There is general agreement that a minimum of 1 year o
specialized training in EPS is needed to acquire the cogni-
tive and technical skills required to become expert in
CCEP. This is in addition to time spent during genera
cardiology fellowship training learning to diagnose and
manage arrhythmias. Training should take place in a labo-
ratory that offers experience with a diverse patient popula-
tion who manifest a broad variety of arrhythmias. During
the specialized training year, it is recommended that each
trainee be a primary operator and analyze 100 to 150 initia
Table 2. Technical Skills Needed to Perform Electrophysiologic
Studies
Operational skills to perform right and left heart catheterization with
percutaneous techniques via femoral and other venous and arterial
access sites
Manual dexterity to safely place and manipulate electrode catheters in
the appropriate chambers for the arrhythmia under study
Ability to obtain appropriate recordings from various locations
Ability to safely perform programmed electrical stimulation
Ability to recognize and manage procedural complications (e.g., vascular
or cardiac perforation)
Proficiency in the use of external defibrillation and intravenous cardiac
medications
Proficiency in the appropriate use of sedation during procedures,
including airway management
Proficiency in the testing, interrogation, and programming of
implantable antiarrhythmic devices, including pacemakers and
defibrillators
Technical knowledge regarding the use of recording equipment,
including knowledge of electrical safety and pertinent radiation-related
issuesdiagnostic studies. At least 50 of these procedures should
involve patients with supraventricular arrhythmias. Because
therapy with antiarrhythmic devices forms a major part o
current electrophysiology practice, the trainee should also
have been a primary operator during greater than or equal to
25 implantation and electrophysiologic evaluations of im-
plantable antiarrhythmic devices. The trainee’s experience
should be documented in writing and confirmed by the
laboratory supervisor. For each procedure during the train-
ing period, the following facts should be documented: date
patient identification number, patient age, indication, type
of procedure, findings, and complications. The 1-year train-
ing period is considered to be the minimum required fo
most individuals to become proficient in basic pacemake
and implantable cardioverter-defibrillator implantation and
management, performance, and interpretation of diagnostic
EPS, and catheter ablation of the common forms o
paroxysmal supraventricular tachycardia. One year of train-
ing also is consistent with ACGME and ABIM require-
ments. This minimum training period however would no
be optimal for an individual who planned on performing
more complex procedures. Responders to the CCEP Train-
ing Program Directors’ Survey strongly felt that 2 years o
training would be preferred for those individuals who desire
training above the basic level needed to satisfy certification
requirements. Because the number and complexity of elec-
trophysiologic procedures continue to expand, electrophysi-
Table 3. Cognitive Skills Needed to Perform Electrophysiologic
Studies (EPS)
Knowledge of current indications for an EPS
Knowledge of contraindications for an EPS
Knowledge of potential complications and management of such
complications
Knowledge of normal and abnormal cardiac anatomy and
electrophysiology
Knowledge of the anatomy and physiology of the normal atrioventricula
conduction system and accessory pathways
Understanding of the intracardiac electrocardiographic signals
Knowledge of various methods of programmed electrical stimulation
Ability to measure conduction intervals and refractory periods;
knowledge of their significance in normal and pathological states
Knowledge of the predictive value of electrophysiological-testing in
patients with various arrhythmias and clinical syndromes
Ability to interpret data derived from electrophysiological testing
Knowledge of the indications for and complications of therapy with
antiarrhythmic devices
Knowledge of the pharmacology of antiarrhythmic drugs and of
sympathetic and parasympathetic agonists and antagonists
Knowledge of the indications for and complications of ablative therapy
Detailed knowledge of recent clinical trials that affect the selection of
patients for EPSologists should be committed to structured, continuing
education throughout their careers.
ss
)
t
t
f
r
s
,
s
.
,
f
.
r
s
r
r
,
s
.
)
r
,
f
l
s
,
s
t
)
r
s
s
.
t
s
1507JACC Vol. 48, No. 7, 2006 Tracy et al.
October 3, 2006:1503–17 ACC/AHA/ACP Clinical Competence StatementALTERNATE ROUTES TO ACHIEVE COMPETENCE
In the absence of completion of the formal 1-year training
program, competence in CCEP is difficult to achieve. The
current requirement for residency education in CCEP a
stated by the ACGME is 1 year of training in an ACGME
electrophysiology program after the completion of an ac-
credited cardiovascular disease residency program (22). Thi
requirement must be met to sit for the ABIM subspecialty
examination in CCEP (23). For those who choose to gain
competency in the performance of EPS but not within an
accredited U.S. program, training should still be completed
in a structured environment. The operator should perform
the same number of the above-listed procedures as currently
recommended for U.S. trainees. He or she should also
participate in courses designed to provide specific instruc-
tion in CCEP. Prior competency statements have suggested
a minimum of 30 h of continuing medical education (CME
every 2 years; this recommendation is endorsed in the
present document. Any such training should be performed
under the supervision and mentorship of a recognized exper
in the field of cardiac electrophysiology who has achieved
board certification by the ABIM in CCEP or an equivalen
degree of training in countries outside the U.S. The trainee
who completes this latter program in a training program
that is not approved by the ACGME will not be eligible to
take the ABIM examination.
MAINTENANCE OF COMPETENCE
As is true for many other procedures, a minimum number o
cases is necessary to ensure continued proficiency in quality
of care. The individual should participate in greater than o
equal to 100 diagnostic EPS per year to maintain skills and
should attend greater than or equal to 30 h of formal CME
(Level 1 category) every 2 years to remain abreast of change
in knowledge and in technology. These cases can include
the diagnostic portions of ablation procedures.
CATHETER ABLATION: OVERVIEW OF THE PROCEDURE
Catheter ablation has revolutionized the field of electro-
physiology. The performance of catheter ablation was ini-
tially accomplished through the delivery of high-energy
direct current (DC) shocks (24,25). These early procedure
had limitations in usefulness and safety because of barotrauma
They also carried the potential for significant complications
such as cardiac tamponade and the early or late occurrence o
sudden death (26,27). Technological advancements in the late
1980s led to the ability to apply continuous-wave unmodulated
radiofrequency energy through catheters to heat myocardium
at the catheter-tissue interface, creating ablative lesions (28)
Although initial success rates were modest (28,29), furthe
development in technology resulted in a technique that ha
replaced DC energy delivery (30,31). Radiofrequency abla-
tion has also quickly supplanted open-heart surgery fo
several arrhythmias and is an acceptable alternative to
long-term drug treatment.The lesions created by radiofrequency are well demar-
cated. This characteristic, along with improved cathete
technology, allows very specific and focal energy delivery
which permits the cure or modification of many arrhyth-
mias. Through targeting of the specific site of origin of the
arrhythmia, as with atrial tachycardia, or through interrup-
tion of a critical pathway needed for the maintenance of a
re-entrant arrhythmia, such as an accessory pathway, many
arrhythmias of various mechanisms can be eliminated. Since
its inception, catheter ablation has grown tremendously in
its application. The number of reported ablation procedure
performed annually in the U.S. has increased from 450 in
1989 to 15000 annually in the most recent U.S. survey (32)
The success rates reported in the 1995 Scheinman (32
survey of 157 laboratories in the U.S. were 97% for AV node
ablations, 90% for accessory pathways in all locations, 94% fo
AV node modifications in the treatment of AV nodal re-entry
72% for the treatment of atrial flutter, and 71% for the
treatment of atrial tachycardia. Complication rates derived
from the Scheinman (32) survey and the 1993 Multicentre
European Radiofrequency Survey (MERFS) from 86 insti-
tutions (33) were reported in just under 4% of AV node
interruptions, 2.6% of accessory pathway ablations, 1.7% o
AV node modifications, and 1.6% of flutter and atria
tachycardia ablations.
Although the incidence of complications is low, seriou
complications can occur and include valvular disruption
coronary occlusion, cerebrovascular accident, and death. In
U.S. centers, procedural deaths occur in 0.2% of patient
who undergo AV node ablation and 0.1% of patients with
accessory pathways (32). The most common complication
in AV node modification has been the development of hear
block through the inadvertent ablation of both the fast and
slow AV nodal pathways. In the 1996 study from the
MERFS (Multicenter European Radiofrequency Survey
(34), 4.7% of patients developed heart block during AV
node modification. Heart block was significantly higher in
patients in whom the fast pathway was targeted (5.3%) rathe
than the slow pathway (2%). This is higher than the overall rate
of inadvertent heart block reported by Calkins et al. (35) from
the Akhtar Multicenter Ablation Investigators Group, in
which the incidence of inadvertent heart block in patient
who underwent AV node modification was 1.3%. Impor-
tantly, a slow pathway ablation approach was used in thi
study. This study also reported serious complications in 3%
of patients and minor complications in 8%.
Despite these complications, studies have clearly shown
that symptomatic patients are afforded important improve-
ments in the quality of life with catheter ablation (36–39)
The benefit gained through arrhythmia treatment with
catheter ablation is superior to that achieved through
medical therapy. The cost of catheter ablation, although no
trivial, is less over time than the cost of alternatives such a
medical therapy or surgical interventions (36,40).
Catheter ablation provides a safe and highly effective
treatment for symptomatic patients with supraventricular
tachycardia. Ablation should not be reserved as a last resort
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ACC/AHA/ACP Clinical Competence Statement October 3, 2006:1503–17treatment but is appropriate to consider, in some cases, a
first-line therapy (e.g., a symptomatic patient with Wolff-
Parkinson-White syndrome) (41–46). However, for pa-
tients with rhythm disturbances that are likely to spontane-
ously resolve (e.g., atrial tachycardia) or unlikely to recu
(e.g., a first episode of atrial flutter), ablation would not be
appropriate first-line therapy (47). Its role would be limited
to patients in whom medical therapy is intolerable or in
whom there is evidence for adverse consequences of the
arrhythmia. The complete list of indications is detailed in
the ACC/AHA guidelines for CCEP and catheter ablation
procedures (17).
Atrioventricular node re-entry in a structurally norma
heart typically is a benign arrhythmia, and there is a
reasonable chance that no therapy is required (48). How-
ever, if patients have other compounding heart disease, such
as coronary artery disease, or if the arrhythmia produce
hemodynamic compromise or intolerable side effects, abla-
tion can be considered as first-line treatment because of the
high likelihood of recurrence or of serious consequences to
the arrhythmia (48).
The area of atrial fibrillation (AF) ablation has undergone
rapid evolution over the last 3 to 5 years. Initial attempts a
catheter ablation attempting to recreate the maze procedure
were only marginally successful and carried relatively high
complication rates. However, the transition to focal ablation
and to now substrate modification with wide area circum-
ferential ablation has led to greater application of thi
technique.
In a recent survey of electrophysiologists, 30% (n  92 o
304 respondents) reported that they performed AF abla-
tions. In this self reporting study, the number of reported
AF ablations from 2000 to 2003 was 5592 AF ablations o
72575 total ablation procedures during the same time period
The self reported 1-month, 1-year, and 2-year success rate
were: 71 4%, 66 5%, 63 6%, respectively. Respondent
reported procedure times of 4.5  0.4 h (49). Othe
published series of ablation for paroxysmal AF ablation
report success rates of approximately 85%, which may
require more than 1 ablation procedure to achieve (50,51)
Large series report complications in the 2% to 11% range
including perforation, tamponade, stroke, pulmonary vein
stenosis, and, with certain lesion sets, atrioesophageal fis-
tula, which is often fatal (52).
It is not anticipated that all trainees would want to pursue
training in AF ablation nor should it be a mandatory part o
training. Atrial fibrillation ablation is of higher risk than
ablation of other arrhythmia substrates, and the trainee
must be aware of the special risks such as pulmonary vein
stenosis; atrioesoghageal fistula; and the higher risk o
stroke, perforation, and tamponade. They must also be
proficient in acute management of potential complications
While the exact lesion set required to treat AF remain
debatable, there are several common elements to the abla-
tion procedures that are currently being performed (53,54)
Access to the left atrium is achieved via transseptal punc-
ture. It is anticipated that the operator will have alreadyacquired experience at performance of transseptal puncture
before performing AF ablation. There are no established
norms for achieving competency in transseptal puncture
but, for a reasonably experienced operator, it would be
expected that performance of 20 supervised transsepta
punctures would display a reasonable amount of competence
(55). The operator should have ready access to transthoracic
echocardiography and be proficient in performing pericar-
diocentesis.
Often visualization with intracardiac echocardiography i
utilized to improve safety and to monitor therapy during
energy delivery during AF ablation (56–58). As such, the
electrophysiologist should be familiar with the placement o
the intracardiac echocardiography catheter and the use o
and interpretation of data acquired. Frequently, AF ablation
is facilitated by using imported 3-dimensional images of the
left atrium acquired either through cardiac magnetic reso-
nance imaging or computed tomography scan (59,60)
These imported data are used in conjunction with real-time
3-dimensional images created with 1 of several electroano-
tomic mapping systems during the ablation procedure. The
electrophysiologist must be familiar with the utility of and
interpretation of these data.
Radiofrequency ablation has been applied in the treatmen
of ventricular tachycardia in ischemic disease, bundle-branch
re-entry, and idiopathic tachycardia (61–64). A decision to
perform an ablation in a patient with ventricular tachycardia
must take into account the risks and benefits of doing so as wel
as subsequent risks of arrhythmia occurrence in abnormal bu
unablated tissue. Techniques such as ablation of ventricula
fibrillation are not within the realm of standard training in
CCEP.
JUSTIFICATION FOR RECOMMENDATIONS
The performance of catheter ablation requires skills detailed
previously as necessary for the performance of diagnostic
electrophysiologic testing. The indications, contraindica-
tions, and complications for catheter ablation are largely
derived from the ACC/AHA Guidelines for Clinical Intra-
cardiac Electrophysiologic and Catheter Ablation Proce-
dures (17). The performance of catheter ablation requires the
ability and dexterity to successfully manipulate catheters in al
locations of the heart to achieve adequate contact between the
catheter and the myocardium to create curative lesions. Thi
requires detailed knowledge of cardiac anatomy. Left-sided
arrhythmia substrates such as left atrial foci usually require
the ability to perform transseptal catheterization (65). In
some laboratories, this approach is routinely used for left-
sided accessory pathways as well. For these pathways
knowledge of trans-septal catheterization and the retrograde
aortic technique is needed (65,66). A thorough knowledge o
arrhythmia mechanisms and the treatment of complex arrhyth-
mias, including pharmacologic effects, is a prerequisite to
catheter ablation. The ability to interpret complex mapping
with multiple intracardiac electrograms is required.
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the application of radiofrequency energy exists either as a
desired end point or as an inadvertent result of energy appli-
cation, physicians who perform ablations should be capable o
managing the bradyarrhythmia and AV heart block.
MINIMUM TRAINING NECESSARY FOR COMPETENCE
Program requirements for residency education in CCEP are
outlined by the ACGME and are effective as of July 1999 (22)
Training in an accredited program is required for admission to
the ABIM examination for certification in CCEP. Program
accredited for training in CCEP must function as a part o
an accredited subspecialty fellowship in cardiovascular dis-
ease. These programs should also meet the training in
specialized electrophysiology, cardiac pacing, and arrhyth-
mia management guidelines outlined by the COCATS
Task Force (21).
The performance of catheter ablation procedures require
skills that are developed over time. Several studies have
shown that success rates improve and fluoroscopy time
decrease with experience (67–70). Although there are many
determinants of arrhythmia recurrences, recurrence rate
drop with operator experience (71). Each of these studie
involved operators with extensive prior experience in elec-
trophysiology, and it would be expected that the number o
procedures required for a new trainee to gain expertise in
ablation would be higher than that for an experienced
electrophysiologist. The risks of ablation similarly have been
reported by experienced operators. The MERFS voluntee
registry reported an overall complication rate of 4.6% a
high-volume centers (100 ablations/year) compared with
5.6% at low-volume centers (50 ablations/year) (33). Simila
data were reported in the 1994 North American Society o
Pacing and Electrophysiology survey, with a 1.5% compli-
cation rate at high-volume centers (50 cases/year) and a
3.2% rate at low-volume centers (20 ablations/year) (64).
It is strongly recommended that all physicians who perform
ablations in the U.S. meet the minimum ACGME training
requirements for education in CCEP. Although credentialing
at most institutions does not require board certification in
CCEP, applicants should have met board requirements. A
stated by the ACGME, the current program requirements fo
training in electrophysiology are for 12 months of specialty
training after the completion of training in cardiovascula
disease. This should provide adequate training for the
performance of routine electrophysiologic procedures
Training in electrophysiology and ablation techniques can
occur simultaneously with incremental responsibility for the
trainee during the entire period. However, most training
program directors agree that to gain proficiency in interven-
tional electrophysiology and catheter ablation, additiona
training is required. Adequate training in all aspects o
electrophysiology, including ablation, is expected to take
up to 2 years depending on the skills of the trainee
The certified year in EP must occur after the completion
of a 3-year training program in cardiovascular disease(19,38,40,41,72,73). Much discussion is underway to
recognize the sentiment that 2 years of training in CCEP
is optimal but may require adjustment in the overal
training of the cardiovascular specialist, but this is beyond
the purview of this paper.
It is anticipated that the more experienced the electro-
physiologist, the quicker she or he will learn new tech-
niques. As such, it is difficult to set requirements for a
number of procedures to gain proficiency. The HRS Ad
Hoc Committee on Catheter Ablation has recommended
that a physician who performs catheter ablation procedure
should have been the primary operator on 30 ablations (74)
this should include 15 accessory pathway ablations. The
Canadian Cardiovascular Society Committee (19) recom-
mends a training experience that includes the performance
of 50 transvenous catheter ablations. The ACGME recom-
mends a minimum of 75 catheter ablative procedures
including a mix of AV nodal re-entrant tachycardia, atria
flutter, AV junction ablation, and ventricular tachycardia
(22). For left-sided mapping procedures, the COCATS
guidelines (21) recommend 15 cases with the retrograde aortic
approach. For transseptal catheterization experience, greate
than 10 procedures are recommended. The COCATS guide-
lines also recommend participation in 75 catheter ablation
procedures. It is the consensus of this task force that, for new
trainees, the physician should be involved in 75 ablation
procedures. It is notable that, for candidates who take the
first cardiac electrophysiology examination given by the
ABIM, the pass rates were significantly higher for those
who performed a greater number of ablations compared
with those who performed a lesser number of procedure
(75). The CCEP Training Program Directors’ Survey
indicated that a minimum of 90 (mean; median, 100) case
were required to acquire clinical competence in cathete
ablation.
No numeric guidelines have been established for training
in AF ablation, but it is anticipated that the trainee should
participate in 30 to 50 mentored AF ablations. These are in
addition to the 75 procedures required to achieve compe-
tency for other ablation procedures.
ALTERNATE ROUTES TO ACHIEVE COMPETENCE
At this time, it is anticipated that physicians who perform
ablations will have either received instruction during thei
training or been among those who developed the technique
In the rare instance of a board-eligible or -certified electro-
physiologist who desires to learn the techniques required fo
ablation, mentoring by an electrophysiologist who is trained
in ablation should be pursued. Documentation of satisfac-
tory completion of such training should be kept in a log
book. It is anticipated that, depending on the level of skill
a minimum of 75 procedures will be required. In addition
such an individual should participate in courses designed to
provide specific instruction in the cognitive and technical
skills required for catheter ablation as listed earlier.
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The field of interventional electrophysiology is evolving
rapidly. Although it is anticipated that most physicians who
perform ablations will have received instructions during
their training, newer techniques will arise that require new
skills or adaptations of old skills. The maintenance of skill
needed to perform ablations successfully with acceptably low
complication rates requires continued clinical activity. It i
recommended that physicians who perform ablations main-
tain a volume of 20 to 50 ablations/year. The CCEP
Training Program Directors’ Survey respondents indicate
that, to maintain competency in catheter ablation, a mean o
38 (median, 50) cases/year are required.
With the future development of new techniques, it is likely
that some form of retraining will be required. Every 2 years
physicians who are involved in ablation therapy should attend
CME activities that pertain to interventional electrophysiol-
ogy. For novel treatments, some form of monitoring should
be considered. The CCEP Training Program Directors
Survey results indicated that, to maintain competency in the
performance of diagnostic EPS, a mean of 49 (median, 50
cases/year was required and that a mean of 49 (median, 50
could be in association with the performance of ablation
procedures.
USE OF EMERGING TECHNOLOGY AND
NEW TECHNIQUES: ASSESSMENT OF
CLINICAL COMPETENCE IN INVASIVE
CARDIAC ELECTROPHYSIOLOGIC PROCEDURES
During the past 10 years, the technology of cardiac electro-
physiology has evolved rapidly. The rather straightforward
electrophysiologic procedures from the diagnostic era have
given way to the multicatheter techniques and accompanying
technologies that are necessary for interventional practice. The
8- to 16-channel analog recording systems are being replaced
in routine procedures with 16- to 48-channel, computer-based
digital recording platforms. Furthermore, 48- to 128-channe
mapping capabilities are being developed and increasingly
applied in cardiac ablation procedures. These systems no
only simultaneously record and display activation from
multiple regions of the heart but also format both activation
and voltage information in 3- and 4-dimensional render-
ings.
Electroanatomic magnetic mapping capabilities, for ex-
ample, are being applied to aid in the diagnosis and
nonpharmacologic treatment of arrhythmias (76,77). These
systems involve the interaction of a sensing unit in the
catheter tip positioned within a triangulating magnetic field
to display temporal activation in a 3-dimensional pseudo-
anatomic context. Noncontact mapping probes are also
being used to record actual and virtual electrograms from
the endocardial surface of each heart chamber. With thi
technology, cardiac activation can be displayed in terms o
3-dimensional isochronal and full cardiac cycle isopotential
maps (78,79). Several other systems that use active signalingbetween multiple exclusively intracardiac catheter electrode
or the body surface and catheter electrodes are being
developed to provide a 3-dimensional framework for cardiac
arrhythmias (80). In each case, these new technologie
increase the amount and complexity of data generated
during a mapping procedure.
Use of cryoablation is gaining popularity in certain
patient populations although its use has not become wide-
spread (81,82). Those in training or who have completed
training must be aware of ongoing developments in energy
delivery systems including new energy sources and othe
components of energy delivery systems (e.g., catheter mod-
ifications, manipulable sheaths, and so on).
Two-dimensional fluoroscopic imaging is also being sup-
plemented with intracardiac echocardiography. This ap-
proach has capabilities of visualizing cardiac structures
endocardial surfaces, and the interaction between interven-
tional catheters and targeted structures that are superior to
those available with fluoroscopy (83–85). Although not ye
established as requisite or “core” equipment for the electro-
physiology laboratory, these and other emerging technolo-
gies have had, and will continue to have, a major impact on
the practice of cardiac arrhythmia management. It is also
anticipated that additional new technologies will be devel-
oped at ever faster rates in the future.
COMPETENCE IN THE USE
OF EMERGING TECHNOLOGY
This evolution of new means of diagnosing and treating
arrhythmias is accompanied by an ever-increasing challenge
to the practicing electrophysiologist. Specifically, the use o
additional techniques and technologies will require the
acquisition of sufficient cognitive and technical expertise to
ensure safe and effective application. Although cardiac
electrophysiology trainees may encounter these approache
and systems during their fellowships, by default, the major-
ity of clinical electrophysiologists will first be exposed to
and begin using, emerging techniques and technologie
outside of their training experience. As such, the skill
required to record, compile, synthesize, integrate, render
interpret, and apply the resulting data will be acquired
through alternative educational pathways.
SPECIFIC TRAINING REQUIREMENTS
The training required for proficiency in the application o
new technologies and techniques will depend on the tech-
nology and procedures under consideration. When emerg-
ing techniques and technology represent straightforward
incremental progress, their use may rely on already residen
cognitive and technical skills. For example, many new
intracardiac mapping technologies involve the same venou
and arterial access skills, arrhythmia induction protocols
catheter positioning and mapping techniques, electrogram
pattern recognition, and arrhythmia mechanism deduction
previously acquired though years of training and clinical
practice. In these cases, training should be focused on the
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application of data displays.
In other cases, however, application of the emerging
techniques and technology will undoubtedly represent a
major paradigm shift in interventional approaches thu
requiring the accumulation of very different technical and
cognitive skills than those required to use the curren
procedures or technology. In such cases, sufficient education
and experience are imperative for both understanding the
general operational principles behind that technology and
ensuring sufficient technical abilities for the safe and effi-
cient application of the technology. This exposure may
come from national and local CME seminars; emerging
scientific information from reputable, established scientific
journals; local or regional training sessions; or on-site
teaching by certified industry engineers. In any event
sufficient experience should be acquired such at the actua
application of the technology and performance of the
procedure are conducted safely under the direction of the
practicing physician, without relegation of this responsibil-
ity to an industry representative. This obviously require
that a practitioner have a sufficient understanding of appro-
priate indications, contraindications, and risks for the ap-
plication of that technology.
The duration of training or number of procedures re-
quired to establish competence will be dependent on the
new techniques or technology used. This should be based on
definable measures of individual competence and should
include appropriate documentation of the specific case
undertaken, arrhythmias under study, general technique
and approaches used, and outcomes of the technology-
related procedures. It is fully anticipated that some new
technologies and techniques will lead to sufficiently special-
ized and frequent applications so as to require subsequent
independent competency guidelines. This has been the case
in both pacemaker and defibrillator implantation and in
cardiac ablation, as discussed in the preceding guidelines.
Finally, because of the additional complexity of interven-
tions enabled through emerging technology, cardiac elec-
trophysiology trainees may require additional time to ac-
quire the fundamental proficiency necessary for an
interventional practice. In any event, it remains increasingly
critical that the practicing physician acquire and maintain an
understanding of relevant fundamental principles of electro-
physiology. Although technological advancements may be
exciting, it should be kept in mind that the technology fo
technology’s sake is to be avoided, especially if there is no
value to the patient. Training in CCEP should include
gaining the insight into when and in whom to intervene
Patient selection and use of alternate therapy is a skill se
that all trainees must acquire.
CLINICAL COMPETENCE IN ELECTIVE
DCCV: OVERVIEW OF THE PROCEDURESince the introduction of DC transthoracic electrical shock
(86), its use has become fairly routine for the termination oftachycardias. A variety of clinical scenarios are now encoun-
tered in which transthoracic and, more recently, intracardiac
DC electrical shock of variable energies is delivered
(25,27,63,87–90). In urgent settings such as hemodynamic
collapse associated with ventricular tachycardia or ventricu-
lar fibrillation, high-energy shock (i.e., greater than 200 J) i
used. However, lower energies are used for elective cardio-
version in more hemodynamically stable patients. Due to
the potential risks involved, it is imperative that physician
be familiar with proper indications, precautions, techniques
and complications (91). Elective DCCV that requires seda-
tion or general anesthesia is the subject of this report. At the
present time, DCCV can be carried out externally with
chest electrodes (transthoracic) or endocardially with the
use of electrode catheters (or leads). The 2 procedures are
discussed separately where appropriate.
A. External Cardioversion
External cardioversion (2) is carried out in a fasting
post-absorptive state with the patient under sedation o
general anesthesia. Adequate electrocardiogram monitoring
is maintained throughout. The electrodes (paddles or pads
are placed in the anteroposterior or base-apex location. Fo
atrial defibrillation, a more superoanterior left paddle posi-
tion is often more effective. A clearly visible artifact tha
indicates the timing of the shock in relation to QRS i
identified. A DC shock is synchronized to the peak of the
QRS. Under no circumstances should the shock be deliv-
ered on the T-wave. Physicians in charge should be thor-
oughly familiar with the device that is used for elective
DCCV.
Significantly lower defibrillation thresholds for both AF
and flutter have been identified with rectilinear biphasic
waveform external defibrillators. These devices are available
in most hospitals (92). The initial shock energy may be a
low as 50 J depending on the type of arrhythmia. However
higher initial energy is significantly more effective than lowe
levels, and an initial shock energy of 200 J or greater i
recommended for electrical cardioversion of AF. No definitive
guidelines have been established for biphasic synergy cardio-
version, but the same principles would apply (93).
After shock delivery, the rhythm is noted, and, if con-
version is unsuccessful, repeat DCCV is attempted with
higher energy. This can be repeated until the arrhythmia
terminates or a decision is made to abandon DCCV.
Before elective DCCV is performed, several precaution
are worth noting:
1. Anticoagulation (94–96). The most common arrhyth-
mia subjected to elective DCCV is AF. The operato
should be familiar with and follow the guidelines fo
anticoagulation in AF (93).
2. Although elective DCCV is effective in terminating a
variety of tachycardias, it has no role in the prevention of
subsequent episodes.
t
r
s
,
.
r
,
r
r
r
s
l
s
t
t
l
f
s
s
s
t
s
l
,
,
f
l
:
s
.
1512 Tracy et al. JACC Vol. 48, No. 7, 2006
ACC/AHA/ACP Clinical Competence Statement October 3, 2006:1503–173. The use of transesophageal echocardiography has been
advocated to identify small atrial thrombi that are no
visible on transthoracic echocardiography. The operato
must be familiar with the appropriate use of this tool in
the evaluation of patients in whom earlier cardioversion
is desired. Anticoagulation with heparin can be initiated
and transesophageal echocardiography performed. If no
clots are seen, cardioversion can be undertaken. Routine
anticoagulation must still be maintained after cardiover-
sion (97).
4. Several untoward and potentially life-threatening event
may occur after DCCV shock; these include: 1) the
induction of ventricular tachycardia/fibrillation; 2) asys-
tole; and 3) transient depression of myocardial function
particularly with repeated shocks and higher energies
Techniques to deal with these situations should be
readily available to prevent potential complications. The
operator should have familiarity with the use of an
intravenous antiarrhythmic such as ibutilide and othe
drugs that may result in the restoration of sinus rhythm
or facilitation of DCCV (98,99). The requirements fo
anticoagulation are the same regardless of whethe
cardioversion is accomplished through DCCV o
pharmacologically.
B. Internal Cardioversion
The use of biphasic defibrillators and the use of ibutilide to
lower the defibrillation threshold in patients refractory to
standard DCCV has lowered the number of patients in
whom cardioversion cannot be achieved. However, in pa-
tients for whom external DCCV was unsuccessful, an
internal shock with the use of electrode catheters has been
successful (100,101). Evolution of this technology ha
facilitated the development and assessment of stand-alone
implantable atrial defibrillators (89). Internal cardioversion
may also be performed during the performance of pulmo-
nary vein isolation (102). Internal cardioversion is per-
formed with the patient under conscious sedation or genera
anesthesia (103,104). Specially designed electrode catheter
with large surface areas are introduced percutaneously and
placed in the right atrium and coronary sinus. The large
surface area is achieved with either a coil or the connection
of several electrodes to a common terminal (88). A standard
bipolar catheter is placed in the right ventricle for precise
timing of ventricular activation and shock delivery. The 2
atrial catheters are used for DCCV (i.e., between the
coronary sinus and right atrium).
Up to 10 J of energy can be safely delivered with the righ
atrium–coronary sinus vector, whereas 200 J has been safely
delivered via an intracardiac–thoracic patch combination. I
is important that the electrode catheters are kept away from
the region of the AV node–His bundle when interna
DCCV is performed. Because of the potential risk o
bleeding, warfarin therapy is usually withheld and resumed
after the procedure. Temporary anticoagulation before and
after the procedure can be accomplished with heparin.
Pre-procedural and post-procedural antiarrhythmic therapyconsiderations are similar to those for external DCCV. The
possible risks of both right heart catheterization with
electrode catheters and the fact that the DC shock i
delivered within the myocardial structures add to specific
complications. The settings in which these procedures are
carried out must be equipped to handle all potential unto-
ward sequelae.
JUSTIFICATION FOR RECOMMENDATIONS
The use of external as well as intracardiac DCCV i
associated with a variety of serious risks to the patient. It i
therefore important that the physicians have the cognitive
skills and the technical know-how to safely conduct these
therapies. Tables 4 to 7 summarize the requirements tha
will be considered essential to acquire. The transthoracic
procedure is widely used for the termination of tachycardia
in both chronic and emergent settings. There is a broad-
based pool of knowledge available regarding the clinica
settings in which DCCV is used, including indications
contraindications, complications, and technologies that are
used. However, there is no formal mechanism to determine
the expertise of an individual who is qualified to perform
DCCV. In previous publications regarding external DCCV
the ACP/ACC/AHA Task Force collected data from
accredited cardiology training programs and made the
recommendations. For internal DCCV, a separate level o
knowledge and skill is required because of the invasive
nature. Tables 4 and 5 outline the cognitive and technica
skills needed to perform effective and safe DCCV.
MINIMUM TRAINING NECESSARY FOR COMPETENCE
For external DCCV, the minimum training should include
1) competence in the interpretation of 12-lead electrocar-
diograms; and 2) cognitive knowledge and skills, outlined in
Tables 6 and 7. It is imperative that the technical skill
required to perform cardioversion are applied by those with
an overall understanding of the procedure. Improperly
performed DCCV can be both ineffective and harmful
Previous task force recommendations of a minimum of 8
Table 4. Cognitive Skills Necessary to Perform Internal DCCV
Physicians should have knowledge of the following:
Intracardiac EPS principles as discussed in this report
Principles of intracavitary cardioversion with catheter technology,
catheters, chest electrodes, or whatever variant the operator plans to
use
Indications and complications associated with transvenous
catheterization and with the intracavitary delivery of DC shock
The safe delivery of DC shock and the limit of energy that can be
delivered via electrode catheters
The use of conscious sedation or, when appropriate, anesthesia
The use of intravenous antiarrhythmic medications
Cognitive skills necessary for external DCCV (see Table 6)DC  direct current; DCCV  DC cardioversion.
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October 3, 2006:1503–17 ACC/AHA/ACP Clinical Competence Statementsupervised DCCVs seem appropriate as a minimum
requirement. Although typical training in cardiovascula
disease during a 3-year period may provide such an experi-
ence, it should be documented by the trainee and certified
by appropriately trained supervisors. If formal training in
cardiovascular disease does not provide adequate exposure to a
sufficient number of DCCVs, competence in DCCV is no
achieved. Conversely, the competence in DCCV may be
achievable without formal training in cardiovascular disease
For competency in internal DCCV, all of the above-
mentioned requirements for external DCCV must be met
It is inconceivable that someone could meet the competency
criteria for internal DCCV without prior established min-
imum training needed for external DCCV. In addition
however, the candidate must meet the minimum compe-
tency requirement for the following:
Table 5. Technical Skills Necessary to Perform Intracardiac
DCCV
Competency in diagnostic cardiac electrophysiologic studies
Ability to place electrode catheters in appropriate locations for
intracardiac synchronization and DCCV
Familiarity with the catheter characteristics, synchronization, and
DCCV equipment
Ability to confirm the timing and energy of the shock for safe shock
delivery
Adequate electrocardiographic and rhythm monitoring equipment
Ability to handle complications, including the use of temporary pacing
and defibrillation
Proficiency in the appropriate use of sedation during procedures,
including airway management
DCCV  direct current cardioversion.
Table 6. Cognitive Skills Necessary to Perform External DCCV
Physicians should have knowledge of the following:
Electrophysiological principles of DCCV
Indications for the procedure
Anticoagulation management
The proper use and administration of antiarrhythmic therapy
The use of sedation and the management of overdose
DCCV equipment, including the selection of appropriate energy and
synchronization
How to treat all possible complications, including the use of bradycardia
pacing, defibrillation, and advanced cardiovascular life support
Proper placement of external paddles or pads
Appropriate monitor display and recognition of pre- and post-DCCV
arrhythmias
Ability to differentiate failure to convert atrial fibrillation from an
immediate recurrence of atrial fibrillation
Baseline 12-lead electrocardiogram reading, recognition of acute
changes, drug toxicity, contraindications to DCCVDCCV  direct current cardioversion.1. Diagnostic invasive EPS as mentioned elsewhere
here.
2. Cognitive and manual skills to ensure the proper place-
ment of electrode catheters and additional chest elec-
trodes when necessary for internal DCCV.
3. Management of complications arising due to the proce-
dure. With the advent of biphasic external defibrillators
the number of patients undergoing internal cardioversion
has decreased except in specialized circumstances. It is no
anticipated that all CCEP trainees will perform thi
technique. However, for those undertaking this procedure
a minimum of 5 intracavitary DCCVs under experienced
(in intracardiac DCCV) individual supervision is recom-
mended. Demonstration of adequate reading of didactic
material and attendance of meetings that address intra-
cavitary DCCV with catheter technology are also rec-
ommended. The supervisor must also document in
writing exactly what was accomplished with the
didactic exposure and during the procedures. Privi-
leges in diagnostic EPS and even radiofrequency
ablation do not automatically qualify one to perform
intracardiac DCCV.
4. Periodic random examination of the outcomes may be
necessary to comply with standards of care, including
proper attention to record keeping regarding indica-
tions, efficacy, and complications.
MAINTENANCE OF COMPETENCE
A minimum of 4 external DCCV procedures annually
should be necessary to maintain initial certification. It is also
important that a new body of knowledge be acquired a
additional reliable data become available. Varying and
changing technology also necessitates that the operator be
familiar with the proper use of external DCCV equipmen
used in his or her clinical settings.
The maintenance of competence in intracardiac DCCV
requires a minimum of 2 annual procedures. In addition
necessary knowledge of upkeep and equipment change
must be maintained. This, of course, is done with the
understanding that competency for diagnostic EPS is mon-
itored concurrently. Individuals with experience in interna
Table 7. Technical Skills Necessary to Perform External DCCV
Proper preparation of the skin and electrode placement, including the
application of saline jelly
Achievement of artifact-free monitored strips and synchronization
signal/marker
Technically acceptable 12-lead electrocardiograms before and after
DCCV
Temporary pacing and defibrillation capabilities
Ability to perform advanced cardiovascular life support, including proper
airway management
DCCV  direct current cardioversion.DCCV within the institution should look at the issue from
the quality control perspective on a periodic basis. An
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